Thromb Haemost 1989; 61(03): 463-467
DOI: 10.1055/s-0038-1646615
Original Article
Schattauer GmbH Stuttgart

Involvement of 5-Hydroxytryptamine in Platelet Aggregation In Vivo in Rats and Guinea Pigs

G M Smith
The School of Pharmacy, Robert Gordon’s Institute of Technology, Aberdeen, Great Britain Key words
› Author Affiliations
Further Information

Publication History

Received 30 September 1988

Accepted after revision 30 January 1989

Publication Date:
24 July 2018 (online)

Summary

In this study, 5-hydroxytryptamine (5-HT) caused a dose- dependent fall in the circulating platelet count suggesting that 5-HT receptors are activated in rat platelets to cause platelet adhesion and aggregation. When low doses of adenosine diphosphate (ADP) were simultaneously injected with 5-HT, there was a significant potentiation of the responses to ADR Ketanserin significantly reduced the potentiated responses. When higher doses of ADP were infused with bolus injections of 5-HT there was no potentiation and ketanserin did not reduce these responses. Ketanserin did not inhibit the collagen-induced fall in circulating platelet count, but did significantly increase the rate of return to the basal platelet count compared with control. 5-HT did not cause a fall in platelet count in guinea-pigs

 
  • References

  • 1 Holmsen H. Prostaglandin endoperoxide - thromboxane synthesis and dense granule secretions positive feedback loops in the propagation of platelet responses during the “The Basic Platelet Reaction”. Thromb Haemostas 1977; 38: 1030-1041
  • 2 de Clerck F, Xhonneux B, Leysen JE, Janssen PA J. Evidence for functional 5-HT2receptor sites on human blood platelets. Biochem Pharmacol 1984; 33: 2807-2811
  • 3 de Clerck F, Xhonneux B, Leysen JE, Janssen PA J. The involvement 5-HT2receptor sites in the activation of cat platelets. Thromb Res 1984; 33: 305-321
  • 4 de Clerck F, David JL, Janssen PA J. Inhibition of 5-Hydroxytrypt-amine-induced and-amplified human platelet aggregation by ketanse-rin (R 41 468), a selective 5-HT2receptor antagonist. Agents Actions 1982; 12: 388-397
  • 5 Joris I, Braunstein PW. Platelets and endothelium: Effect of collagen- induced platelet aggregates on pulmonary vessels. Exp Mol Pathol 1982; 37: 393-405
  • 6 Chignard M, Le Couedic JP, Tence M, Vargaftig BB, Benveniste J. The role of PAF in platelet aggregation. Nature 1980; 279: 495
  • 7 Mallarkey G, Smith GM. In vivo platelet aggregation in the rat. The dependence on extracellular divalent cation and inhibition by non-steroidal anti-inflammatory drugs Br J Pharmacol 1984; 84: 425-430
  • 8 Sneddon JM. Sodium-dependent accumulation of 5-hydroxytrypt- amine by rat blood platelets. Br J Pharmacol 1969; 37: 680-688
  • 9 Stoltz JF. Uptake and storage of serotonin by platelets. In: Serotonin and the Cardiovascular System. Vanhoutte PM. (ed) Raven Press; New York: 1985. pp 37-42
  • 10 Drummond AH. Interaction of blood platelets with biogenic amines: Uptake stimulation and receptor binding. In: Platelets in Biology and Pathology. Gordon JL. (ed) Elsevier-North Holland Biomedical Press; New York: 1976. pp 203-239
  • 11 De Felipe MC, Fuentes JA, Drummond AH. Specific 5-hydroxy-tryptamine binding to rat platelets as a system to evaluate tricyclic antidepressants in plasma. Biochem Pharmacol 1982; 31: 1661-1663
  • 12 Mallarkey G, Smith GM. A comparative study of the involvement of the prostaglandin H/thromboxane A2pathway in intravascular platelet aggregation in guinea-pigs and rats. Br J Pharmacol 1985; 84: 425-430
  • 13 Jones RL, Smith GM, Wilson NH. The effects of a synthetic prostanoid EP 092 on intravascular platelet aggregation and bron-choconstriction. Br J Pharmacol 1982; 64: 100 P
  • 14 Smith GM, Freuler F. The measurement of Intravascular Aggregation by Continuous Platelet Counting. Bibl Anat 1973; 12: 229-234
  • 15 Smith GM. A study of intravascular platelet aggregation by continuous platelet counting. Trends Pharmacol Sci 1982; 105-107
  • 16 Van Nueten JM, Janssens WJ, Vanhoutte PM. Serotonin and vascular smooth muscle. In: Serotonin and the Cardiovascular System. Vanhoutte PM. (ed) Raven Press; New York: 1985. pp 95-103
  • 17 Holmsen H. Platelet activation and Serotonin. In: Serotonin and the Cardiovascular System. Vanhoutte PM. (ed) Raven Press; New York: 1985. pp 75-86
  • 18 Holmes IB, Smith GM, Freuler F. The effect of intravenous adenosine diphosphate on the number of circulating platelets in experimental animals: inhibition by prostaglandin E1, dipyridamole, SH-869 and VK-774. Thromb Haemostas 1977; 37: 36-46
  • 19 Tapparelli C, Gfeller P, Sanjar S, Morley J. Comparison between in vitro and in vivo aggregation of platelets. Thromb Haemostas 1987; 58 (01) 470 (Abstr 1740)